Sentiss Pharma Private Limited — Dexamethasone Exporter Profile
Indian Pharmaceutical Exporter · #7 for Dexamethasone · $4.5M export value · DGFT Verified
Sentiss Pharma Private Limited is the #7 Indian exporter of Dexamethasone with $4.5M in export value and 90 verified shipments. Sentiss Pharma Private Limited holds a 2.5% market share in Dexamethasone exports across 6 countries. The company exports 6 pharmaceutical products worth $28.3M across 4 therapeutic categories.
Sentiss Pharma Private Limited — Dexamethasone Export Profile: Buyers & Destinations
Where Does Sentiss Pharma Private Limited Export Dexamethasone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $1.6M | 39 | 59.0% |
| KAZAKISTAN | $438.9K | 10 | 15.9% |
| KAZAKHSTAN | $259.6K | 6 | 9.4% |
| KYRGHYSTAN | $182.9K | 16 | 6.6% |
| UZBEKISTAN | $119.6K | 6 | 4.3% |
| KYRGYZSTAN | $119.3K | 11 | 4.3% |
| GERMANY | $5.0K | 1 | 0.2% |
| UKRAINE | $4.9K | 4 | 0.2% |
Sentiss Pharma Private Limited exports Dexamethasone to 8 countries. The largest destination is RUSSIA accounting for 59.0% of Sentiss Pharma Private Limited's Dexamethasone shipments, followed by KAZAKISTAN (15.9%) and KAZAKHSTAN (9.4%). These destinations reflect Sentiss Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Dexamethasone from Sentiss Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LLC SENTISS RUS | RUSSIA | $1.2M | 27 |
| LLC ?SENTISS RUS? | RUSSIA | $398.9K | 11 |
| ALG COMPANY JSC | KAZAKISTAN | $323.8K | 7 |
| ALG COMPANYJSC, | KAZAKISTAN | $174.9K | 4 |
| NEMAN-PHARM LTD | KYRGHYSTAN | $138.4K | 11 |
| ALG COMPANY JSC, | KAZAKISTAN | $114.0K | 3 |
| LLC FARMAMIR | KYRGHYSTAN | $56.7K | 5 |
| ALG CO | KAZAKHSTAN | $50.0K | 1 |
| GRAND PHARM TRADE" LLC | UZBEKISTAN | $36.6K | 1 |
| GRAND PHARM TRADE LLC | UZBEKISTAN | $36.1K | 3 |
Sentiss Pharma Private Limited supplies Dexamethasone to 25 buyers globally. The largest buyer is LLC SENTISS RUS (RUSSIA), followed by LLC ?SENTISS RUS? (RUSSIA) and ALG COMPANY JSC (KAZAKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Dexamethasone Export Value and How Much Does Sentiss Pharma Private Limited Contribute?
India exported $32.1M worth of Dexamethasone through 8,777 shipments from 808 suppliers to 176 countries, serving 2,257 buyers globally. Sentiss Pharma Private Limited contributes $4.5M to this total, accounting for 2.5% of India's Dexamethasone exports. Sentiss Pharma Private Limited ships Dexamethasone to 8 countries through 25 buyers.
What Is the Average Shipment Value for Sentiss Pharma Private Limited's Dexamethasone Exports?
Sentiss Pharma Private Limited's average Dexamethasone shipment value is $50.0K per consignment, based on 90 shipments totaling $4.5M. The largest destination is RUSSIA (59.0% of Sentiss Pharma Private Limited's Dexamethasone exports).
How Does Sentiss Pharma Private Limited Compare to Other Indian Dexamethasone Exporters?
Sentiss Pharma Private Limited ranks #7 among 808 Indian Dexamethasone exporters with a 2.5% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($6.1M), SENTISS PHARMA PRIVATE LIMITED ($4.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.3M). Sentiss Pharma Private Limited processed 90 shipments to 6 destination countries.
What Dexamethasone Formulations Does Sentiss Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| KOMBINIL ? EYE AND EAR DROPS, (VIAL-DROPPER PLASTIC) 5 ML NO.1,BAR#8901236012107,SALT#DEXAMETHASONE & CIPROFLOXACIN ****VLS | $261.2K | 6 |
| KOMBINIL EYE AND EAR DROPS VIAL DROPPERPLASTIC 5ML NO 1 BAR 8901236012107 SALT DEXAMETHASONE CIPROFLOXACIN | $186.7K | 4 |
| KOMBINIL (R) EYE AND EAR DROPS,(VIAL-DROPPER PLASTIC)5 ML NO. 1 Bar#8901236020188 Salt#:DEXAMETHASONE & CIPROFLOXACIN | $150.0K | 3 |
| KOMBINIL EYE AND EAR DROPS,(VIAL-DROPPERPLASTIC)5 ML NO.1,BAR#8901236012107,SALT#DEXAMETHASONE&CIPROFLOXACIN **** | $149.9K | 3 |
| KOMBINIL-DUO EYE /EAR DROPS 5ML,BAR#8901236030477,CIPROFLOXACIN&DEXAMETHASONE, B/N:N23400,N23408,N23400MD:12/23 ED:12/26VLS | $140.2K | 3 |
| KOMBINIL EYE AND EAR DROPS(VIAL-DROPPERPLASTIC)5ML NO.1BAR#8901236012107SALT#DEXAMETHASONE & CIPROFLOXACIN####VLS | $124.6K | 3 |
| KOMBINIL -DUO Eye / Ear Drops 5ml Bar#8901236030477 Salt#Ciprofloxacin & Dexamethasone B/N:N24079 MD:03/24 ED:03/27 | $114.0K | 3 |
| KOMBINIL EYE AND EAR DROPS,(VIAL-DROPPERPLASTIC) 5 ML NO.1,BAR#8901236020188,SALT#DEXAMETHASONE & CIPROFLOXACIN **** | $100.0K | 2 |
| KOMBINIL ? Eye and Ear drops, (vial-dropper plastic) 5 ml No.1 Bar#8901236020188Salt#Dexamethasone & Ciprofloxacin**** | $100.0K | 2 |
| KOMBINIL DUO EYE EAR DROPS 5ML BAR 8901236012107 SALT CIPROFLOXACIN DEXAMETHASONE B N N23061 MD 02 23 ED 02 26 | $50.0K | 1 |
Sentiss Pharma Private Limited exports 64 distinct Dexamethasone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is KOMBINIL ? EYE AND EAR DROPS, (VIAL-DROPPER PLASTIC) 5 ML NO with 6 shipments worth $261.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Sentiss Pharma Private Limited Compare to Nearest Dexamethasone Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MYLAN LABORATORIES LIMITED | $6.1M | 135 | 4 | $45.1K |
| 7 | SENTISS PHARMA PRIVATE LIMITED ★ | $4.5M | 90 | 6 | $50.0K |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $3.3M | 65 | 5 | $50.0K |
| 8 | EUGIA PHARMA SPECIALITIES LIMITED | $3.2M | 64 | 1 | $50.0K |
Sentiss Pharma Private Limited ranks #7 among 808 Indian Dexamethasone exporters. Average shipment value of $50.0K compared to the market average of $39.8K. The closest competitors by value are MYLAN LABORATORIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Dexamethasone Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,214 | 13.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,121 | 12.8% |
| NHAVA SHEVA SEA (INNSA1) | 748 | 8.5% |
| DELHI AIR CARGO ACC (INDEL4) | 509 | 5.8% |
| DELHI AIR | 476 | 5.4% |
| JNPT/ NHAVA SHEVA SEA | 472 | 5.4% |
| Bombay Air | 327 | 3.7% |
| JNPT | 320 | 3.6% |
Geopolitical & Trade Policy Impact on Sentiss Pharma Private Limited's Dexamethasone Exports
Recent geopolitical tensions have significantly impacted global shipping routes, affecting Indian pharmaceutical exporters like Sentiss Pharma. The Israel-Iran conflict has led to heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute vessels around the Cape of Good Hope. This diversion has extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes. (livemint.com)
Additionally, the U.S. has imposed tariffs on pharmaceutical imports, aiming to reduce reliance on foreign generics. While Indian manufacturers supply a significant portion of U.S. generics, tariffs exceeding 10–15% could lead to market exits due to thin profit margins, potentially disrupting supply chains. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive requires stringent quality controls and traceability measures. For companies like Sentiss, adhering to these regulations is crucial to maintain market access and competitiveness.
Sentiss Pharma Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set stringent quality benchmarks. Non-compliance can lead to import bans and reputational damage, as seen in past instances where Indian companies faced restrictions due to quality issues. (comcec.org)
Sentiss Pharma's acquisition of Akorn AG, with its U.S. FDA-approved facility, indicates a commitment to meeting these high standards. This strategic move not only enhances manufacturing capabilities but also ensures adherence to regulatory requirements in key markets. (crisilratings.com)
About Sentiss Pharma Private Limited
Sentiss Pharma Private Limited exports 6 products worth $28.3M. Beyond Dexamethasone, top products include Ciprofloxacin, Ofloxacin, Levofloxacin, Tobramycin, Vati. View the complete Sentiss Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dexamethasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dexamethasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sentiss Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 93 individual customs records matching Sentiss Pharma Private Limited exporting Dexamethasone, covering 64 formulations to 8 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 176+ countries, 2,257+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dexamethasone Export Data from Sentiss Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sentiss Pharma Private Limited's Dexamethasone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sentiss Pharma Private Limited
Full Company Profile →
6 products · $28.3M total trade · 4 categories
Dexamethasone Stats
Company Overview
Top Products by Sentiss Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sentiss Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dexamethasone. For current shipment-level data, contact TransData Nexus.